Quantcast

Latest HspE7 Stories

2008-09-25 09:00:54

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced completion of its U.S. Food and Drug Administration (FDA) pivotal clinical trial for its LightTouch(TM) non-invasive cervical cancer detection device.

2008-09-15 09:00:58

The FDA has approved Merck & Co's Gardasil vaccine for the prevention of vaginal and vulvar cancer caused by human papillomavirus types 16 and 18 in girls and women ages nine to 26.

2008-08-12 09:01:37

SAN DIEGO, Aug. 12 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today financial results for the second quarter and six months ended June 30, 2008, and highlighted several recent product developments and corporate milestones.

2008-07-28 09:01:47

SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that it has completed analysis of immunological data from all four cohorts of its Phase 1 clinical trial for HspE7, its lead product candidate.

834d3ce0350bfc1014c3a7a8c731293e1
2008-04-25 09:49:48

Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer.

2006-09-04 02:00:00

GlaxoSmithKline's experimental vaccine against a virus that causes cervical cancer could cut the number of cases and deaths from the illness by up to 76 percent, the drug company said on Monday.

2006-09-04 02:00:00

GlaxoSmithKline's experimental vaccine against a virus that causes cervical cancer could cut the number of cases and deaths from the illness by up to 76 percent, the drug company said on Monday.

2006-04-06 00:45:00

A vaccine that protects women against a virus that causes cervical cancer is effective for more than four years, researchers said on Thursday.

2006-04-05 14:30:00

LONDON (Reuters) - A vaccine that protects women against a virus that causes cervical cancer is effective for more than four years, researchers said on Thursday.

2005-12-26 09:24:32

NEW YORK (Reuters Health) - Women with certain types of human papilloma virus (HPV) infection run the risk of developing CIN -- cervical intraepithelial neoplasia, a type of pre-cancer.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related